• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Global X Genomics & Biotechnology ETF (NQ: GNOM )

    9.835 -0.143 (-1.43%)
    Official Closing Price Updated: 4:15 PM EST, Dec 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 71,654
    Open 9.930
    Bid (Size) 9.530 (1)
    Ask (Size) 11.00 (1)
    Prev. Close 9.978
    Today's Range 9.790 - 10.00
    52wk Range 9.520 - 12.53
    Shares Outstanding 33,418,720
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Gene Editing Stocks with Potential to Transform Medicine
    Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks. 
    Via InvestorPlace
    The 3 Best Gene Editing Stocks to Buy in July 2024
    Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. 
    Via InvestorPlace

    Performance

    YTD
    -15.80%
    -15.80%
    1 Month
    -9.19%
    -9.19%
    3 Month
    -11.79%
    -11.79%
    6 Month
    -5.80%
    -5.80%
    1 Year
    -16.44%
    -16.44%

    More News

    Read More
    Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
    Via InvestorPlace
    3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
    Via InvestorPlace
    3 Stocks That Could Be the Next Big Thing in Gene Editing
    Via InvestorPlace
    ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play?
    Via Talk Markets
    3 Gene Editing Stocks With Unprecedented Surge Potential
    Via InvestorPlace
    3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential
    Via InvestorPlace
    3 Gene Editing Stocks to Generate Super-Charged Gains
    Via InvestorPlace
    The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
    Via InvestorPlace
    The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
    Via InvestorPlace
    3 Gene Editing Stocks With the Best Long-Term Potential
    Via InvestorPlace
    3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
    Via InvestorPlace
    ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM
    Via Talk Markets
    A Comprehensive Guide To Genomic ETFs
    Via Talk Markets
    Top-Performing Biotech ETFs of Last Week
    Via Talk Markets
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.